| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/18/2001 | US6291157 Detecting retroviral antigens in samples by immunizing the host with an immunogenic non-infectious, non-replicating virus particles producing antibodies, mixing sample with retroviral antigen antibodies, detecting immune complexes |
| 09/18/2001 | US6291156 Plant pest control |
| 09/18/2001 | US6291155 Self assembly of sensor membranes |
| 09/18/2001 | US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 09/18/2001 | US6290964 Isolated from the clear gel isolated from the whole leaf of the aloe vera plant. |
| 09/18/2001 | US6290839 Systems for electrophoretic transport and detection of analytes |
| 09/18/2001 | CA2238879C Thereapeutic applications for the anti-t-bam (cd40-l) monoclonal antibody 5c8 |
| 09/18/2001 | CA2145182C Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 09/18/2001 | CA1341292C The manufacture and expression of consensus human leukocyte interferon |
| 09/15/2001 | WO2001066747A2 Proteins named fctrx and nucleic acids encoding same |
| 09/15/2001 | CA2401552A1 Proteins named fctrx and nucleic acids encoding same |
| 09/13/2001 | WO2001067369A2 Combinatorial array for nucleic acid analysis |
| 09/13/2001 | WO2001067129A2 Epoxide polymer surfaces |
| 09/13/2001 | WO2001067110A1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 09/13/2001 | WO2001067107A1 Modulation of histone deacetylase |
| 09/13/2001 | WO2001067105A1 Carriers coated with polysaccharides, their preparation and use |
| 09/13/2001 | WO2001067103A1 Function homology screening |
| 09/13/2001 | WO2001067102A2 Detection of chitin-containing contaminants such as microorganisms |
| 09/13/2001 | WO2001067099A1 Measurement of substances in liquids |
| 09/13/2001 | WO2001067081A1 Biosensor and method of producing the same |
| 09/13/2001 | WO2001066805A1 Method of monitoring hiv assembly and maturation |
| 09/13/2001 | WO2001066804A2 Methods for optimizing hybridization performance of polynucleotide probes and localizing and detecting sequence variations |
| 09/13/2001 | WO2001066803A2 Phytomics: a genomic-based approach to herbal compositions |
| 09/13/2001 | WO2001066802A1 SYSTEMS AND METHODS TO QUANTIFY AND AMPLIFY BOTH SIGNALING AND PROBES FOR cDNA CHIPS AND GENES EXPRESSION MICROARRAYS |
| 09/13/2001 | WO2001066801A2 Very low density lipoprotein receptor polymorphisms and uses therefor |
| 09/13/2001 | WO2001066800A2 Human single nucleotide polymorphisms |
| 09/13/2001 | WO2001066799A2 Real time quantitative pcr with intercalating dye for single and multiplex target dna |
| 09/13/2001 | WO2001066798A2 Random truncation and amplification of nucleic acid |
| 09/13/2001 | WO2001066797A2 Multiplex hybridization system for identification of pathogenic mycobacterium and method of use |
| 09/13/2001 | WO2001066796A1 Method and system for the simultaneous and multiple detection and quantification of the hybridization of molecular compounds such as nucleic acids, dna, rna, pna and proteins |
| 09/13/2001 | WO2001066795A1 Method for analysing the length of a nucleic acid molecule |
| 09/13/2001 | WO2001066794A1 Molecular methods for detecting guar gum additions to locust bean gum |
| 09/13/2001 | WO2001066793A2 Nucleic acid and oligonucleotides derived therefrom for specifically amplifying and specifically detecting aquaporin genes from vitis spec. |
| 09/13/2001 | WO2001066792A1 Adjuvant activity through modulation of animal and plant cell membrane transport |
| 09/13/2001 | WO2001066790A2 Detection of aspergillus fumigatus |
| 09/13/2001 | WO2001066788A2 Colorimetric mutagenized enzyme screening in microcolonies |
| 09/13/2001 | WO2001066787A1 Improved reverse n-hybrid screening method |
| 09/13/2001 | WO2001066785A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | WO2001066775A2 Dna joining method |
| 09/13/2001 | WO2001066772A2 Heparinase iii and uses thereof |
| 09/13/2001 | WO2001066762A1 Human extracellular signal regulated kinases |
| 09/13/2001 | WO2001066761A1 Inorganic pyrophosphatases from lepidopters |
| 09/13/2001 | WO2001066753A2 Human genes and gene expression products |
| 09/13/2001 | WO2001066746A2 G-protein coupled receptor related polypeptides |
| 09/13/2001 | WO2001066742A2 G-protein coupled receptors |
| 09/13/2001 | WO2001066741A2 Kcnb: a novel potassium channel protein |
| 09/13/2001 | WO2001066732A1 Human abc transporter expressed in liver, atil |
| 09/13/2001 | WO2001066721A2 Nucleic acid sensor molecules |
| 09/13/2001 | WO2001066719A1 Novel gene cloned in human neuroblastoma and novel gene fragments |
| 09/13/2001 | WO2001066716A1 Polypeptide having phosphodiesterase activity |
| 09/13/2001 | WO2001066706A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066688A1 Lateral flow pcr with amplicon concentration and detection |
| 09/13/2001 | WO2001066687A1 Integrated nucleic acid hybridization devices |
| 09/13/2001 | WO2001066597A2 Inflammation-related gene |
| 09/13/2001 | WO2001066595A2 Human fgf-23 gene and gene expression products |
| 09/13/2001 | WO2001066594A2 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | WO2001066572A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 09/13/2001 | WO2001066563A2 T1r taste receptors and genes encoding same |
| 09/13/2001 | WO2001066557A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066556A1 5-pyrimidine-containing nucleic acids and reversible ligation method by using the same |
| 09/13/2001 | WO2001066555A1 Methods for assay and detection on a microarray |
| 09/13/2001 | WO2001066244A1 Materials with silicon-containing layers for use in miniaturized arrays and methods of manufacturing |
| 09/13/2001 | WO2001066107A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | WO2001065998A2 Methods for the diagnosis and treatment of breast cancer |
| 09/13/2001 | WO2001065994A2 Method of and kit for assessing responsiveness of cancer patients to antifolate chemotherapy |
| 09/13/2001 | WO2001036482A8 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 09/13/2001 | WO2001029178A3 Epo primary response gene 1, eprg1 |
| 09/13/2001 | WO2001018545A3 Method for identifying binding partners with position-specific arrays |
| 09/13/2001 | WO2001016288A3 Dna encoding the human serine protease c-e |
| 09/13/2001 | WO2001011010A3 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 09/13/2001 | WO2001009347A9 Archaeal replication accessory factors and methods of use |
| 09/13/2001 | WO2001009305A3 Purine metabolism genes in plants |
| 09/13/2001 | WO2001004343A9 A method for determining the prognosis of cancer patients by measuring levels of bag expression |
| 09/13/2001 | WO2001000875A3 Novel methods and products for arrayed microsphere analysis |
| 09/13/2001 | WO2001000865A3 Amperometric sensor |
| 09/13/2001 | WO2000073797A3 Homogeneous tests for sequentially determining lipoprotein fractions |
| 09/13/2001 | WO2000072019A3 Liposome-enhanced test device and method |
| 09/13/2001 | WO2000063370A3 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 09/13/2001 | WO2000062795A3 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 09/13/2001 | WO2000060120A3 Methods of detecting microorganism using immobilized probes |
| 09/13/2001 | WO2000047600A9 Photo-induced nucleic acid hybridization |
| 09/13/2001 | WO2000043790A9 Compositions and methods for the diagnosis and treatment of tumor |
| 09/13/2001 | WO2000039347A9 A tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein |
| 09/13/2001 | WO2000039336A9 Methods of characterizing drug activities using consensus profiles |
| 09/13/2001 | WO1995021922A3 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 09/13/2001 | WO1995000064A3 Immediate diagnosis of vaginal yeast infections |
| 09/13/2001 | US20010021702 Newly identified polypeptides and polynucleotides that encode them; used in identifying compounds which may be agonists, antagonists and/or inhbitors which are can be useful in therapy |
| 09/13/2001 | US20010021700 Vectors, host cells, antibodies, and recombinant and synthetic methods for producing polynucleotides and the polypeptides they encode |
| 09/13/2001 | US20010021535 Detecting and/or quantifying anibody and antigen analytes using affinity capture; quantification by normalizing and calibrating the obtained mass spectrum against the mass spectrum obtained for known antibody/antigen concentrations |
| 09/13/2001 | US20010021534 Multi-array, multi-specific electrochemiluminescence testing |
| 09/13/2001 | US20010021533 Multi-partite ligands and methods of identifying and using same |
| 09/13/2001 | US20010021532 Using cells comprising promoters having an AP1 site linked to a reporter gene so compounds capable of blocking or inducing expression of the reporter gene can be identified |
| 09/13/2001 | US20010021526 Immortal rho degrees cell line; undifferentiated cells for drug screening; alzheimers, huntington's disease, myoclonic epilepsy lactic acidosis and stroke (MELAS); myoclonic epilepsy ragged red fiber (MERRF) |
| 09/13/2001 | US20010021518 Contacting a mixture of single stranded mRNA and double stranded nucleic acid material with a liquid comprising a chaotropic agent and a nucleic acid binding solid phase, solid phase binds double-stranded nucleic acid, not single |
| 09/13/2001 | US20010021510 Materials and methods for detection and treatment of immune system dysfunctions |
| 09/13/2001 | US20010021507 Renal nuclear matrix protein able to differentiate cancerous renal cell from normal renal cells; useful for diagnosis and producing treatment for cell proliferative disorders of the kidney |
| 09/13/2001 | US20010021506 The functionalized silicon compound containing one or more derivatizable functional group selected from the group consisting of hydroxyl, amino, amido, carboxyl, thio, halo and sulfonate, and one or more acativated silicon group |
| 09/13/2001 | US20010021504 Bringing a sample nucleic acid complex composed of a double-stranded nucleic acid structure and a labeled intercalator, into aqueous medium, applying variation of surrounding conditions to cause detaching of fragment and intercalator |
| 09/13/2001 | US20010021502 Detecting an alteration in an A-T gene which is associated with breast cancer in a human, if the alteration is in germline it is associated with predisposition to breast cancer and if it is in somatic tissue it indicates cancer |
| 09/13/2001 | US20010021501 Providing a sample suspected of containing enterovirus and a mixed cell culture comprising at least two cell types which are RD cells and human mucoepidermoid cells, incubating the culture with sample to produce inoculated culture, observing |